Ksilink
Exhibitor
Phenotypic screening is a versatile and impactful tool in the quest to develop therapies for rare disorders. By leveraging unbiased, functional approaches in disease-relevant cellular systems, this method overcomes many of the limitations of traditional drug discovery and offers renewed hope to patients affected by conditions that have long been neglected by mainstream research. Ksilink is a French TechBio company revolutionizing phenotypic drug discovery through a proprietary platform that integrates patient-derived cellular diseases models with advanced AI-powered cellular profiling and high-throughput high-content screening. Headquartered in Strasbourg, the company offers unique capabilities for the discovery of novel MOAs abd drug candidates with unmatched clinical predictivity.
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events